Healthcare Finance News January 31, 2025
Jeff Lagasse

CMS should bar PBMs from requiring pharmacies to participate in the program, says association survey.

The National Community Pharmacists Association has submitted comments to the Centers for Medicare and Medicaid Services warning that more than 90% of independent pharmacies may decide, or have already decided, to not stock drugs in the Medicare Drug Price Negotiation Program because of the potential financial losses.

“Pharmacies will have to float thousands of dollars every month waiting for refunds from the manufacturers. That will cause a massive cash flow problem in an environment where thousands of pharmacies have already closed,” said NCPA CEO B. Douglas Hoey.

In its comments, NCPA cited a recent national survey of independent pharmacists that found 93.2% of respondents have...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
ASHP to CMS: 'Change course' on drug pricing
Measuring Progress for Life Sciences: Trust, Patient Access, and Prevention at a Fork in the Road of Public Health
2025 Pharma Forecast: Four Pivotal Trends Revolutionizing Market Access Strategies
Christophe Weber, veteran Takeda CEO, to retire next year
Walmart To Expand Same-Day Prescription Delivery Nationwide

Share This Article